JACQUELINE CORRIGAN-CURAY was selected as the permanent director of the FDA Office of Medical Policy at the Center for Drug Evaluation and Research. Corrigan-Curay most recently served as a supervisory medical officer with the Immediate Office of the Director at NIH’s National Heart, Lung, and Blood Institute, where she worked on establishing a new trans-NHLBI...
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.
